$1.08 $0.03 (2.9%)

04:30 PM EST on 02/28/20

Depomed Inc Com (NASDAQ:ASRT)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Current Price $1.08 Mkt Cap $84.7M
Open $1.01 P/E Ratio 0.00
Prev. Close $1.05 Div. (Yield) $0.00 (0.0%)
Daily Range $1.01 - $1.11 Volume 1,478,316
52-Wk Range $1.01 - $1.71 Avg. Daily Vol. 2,288,150

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

238 Outperform
13 Underperform
 

All-Star Players

20 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ASRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zarrpac (< 20)
Submitted June 25, 2017

Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.

ssbb123 (29.64)
Submitted February 22, 2010

"Cancer risk" can't see this being a good investment for the next few months at least.http://www.forbes.com/2010/02/18/xenoport-glaxosmithkline-depomed-markets-equities-pharmaceuticals.html?partner=yahootix

NASDAQ:ASRT VS S&P 500 (SPY)

Fools bullish on NASDAQ:ASRT are also bullish on:

Fools bearish on NASDAQ:ASRT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ASRT.

Recs

0
Member Avatar NorthSeaAscend (55.43) Submitted: 7/24/2018 11:30:16 PM : Outperform Start Price: $8.18 NASDAQ:ASRT Score: -91.64

volatile.

Recs

1
Member Avatar zarrpac (< 20) Submitted: 6/25/2017 6:59:24 AM : Outperform Start Price: $11.11 NASDAQ:ASRT Score: -111.21

Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.

Recs

0
Member Avatar cptsintl (38.40) Submitted: 8/11/2015 2:39:39 PM : Outperform Start Price: $19.97 NASDAQ:ASRT Score: -150.86

.

Leaderboard

Find the members with the highest scoring picks in ASRT.

Score Leader

zzlangerhans

zzlangerhans (99.62) Score: +420.75

The FDA approval curse claims yet another victim.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 30.05 4/20/2009 Underperform NS $2.14 -49.53% +248.40% +297.93 0 Comment
ZeroDotCom 92.90 10/9/2009 Underperform 5Y $5.80 -81.38% +176.58% +257.96 0 Comment
BuyTheDip 46.57 10/13/2009 Underperform 5Y $3.90 -72.31% +174.65% +246.96 0 Comment
joebowler210 94.29 10/14/2009 Underperform 3M $3.73 -71.05% +171.29% +242.34 0 Comment
ssbb123 29.64 2/22/2010 Underperform 3M $2.46 -56.10% +164.74% +220.84 1 Comment
WorldOnFire 27.89 2/2/2011 Underperform 3W $8.31 -87.00% +126.19% +213.19 0 Comment
reed127 < 20 6/14/2012 Underperform 1Y $4.99 -78.36% +122.87% +201.23 0 Comment
bankruptor < 20 11/24/2006 Underperform 3W $3.45 -68.70% +123.23% +191.93 0 Comment
PDTBiotech 80.65 9/28/2012 Underperform NS $5.86 -81.57% +105.43% +187.00 0 Comment
headyinvestor 79.53 9/26/2012 Underperform 5Y $5.80 -81.38% +105.55% +186.93 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ASRT.